Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

36.59 -1.34 (-3.53%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)

August 14, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher ↗

August 14, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...

Via Benzinga

Topics Stocks

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today? ↗

August 14, 2023

With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications.

Via InvestorPlace

The Latest Analyst Ratings for Harmony Biosciences ↗

August 01, 2023

Via Benzinga

Harmony Biosciences's Earnings Outlook ↗

July 31, 2023

Via Benzinga

Analyst Expectations for Harmony Biosciences's Future ↗

June 23, 2023

Via Benzinga

Harmony Biosciences Earnings Perspective: Return On Capital Employed ↗

May 08, 2023

Via Benzinga

Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals ↗

August 14, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

August 14, 2023

Via Benzinga

Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today? ↗

August 14, 2023

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares are skyrocketing Monday after Harmony Biosciences (NASDAQ: HRMY) announced it will

Via Benzinga

7 ‘Strong Buy’ Value Stocks You Should Be Loading Up On Now ↗

August 03, 2023

Although ultra-cheap ideas tend to carry significant risks, these strong buy value stocks offer the endorsement of analysts.

Via InvestorPlace

Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript ↗

August 01, 2023

HRMY earnings call for the period ending June 30, 2023.

Via The Motley Fool

Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates

August 01, 2023

From Harmony Biosciences

Via GlobeNewswire

Analyst Expectations for Harmony Biosciences's Future ↗

May 03, 2023

Via Benzinga

Earnings Outlook For Harmony Biosciences ↗

May 01, 2023

Via Benzinga

Analyst Ratings for Harmony Biosciences ↗

April 17, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

7 Best High-Growth Stocks to Buy if You’re a Young Investor ↗

June 29, 2023

If you’re just starting out and have plenty of time to work with, these are the high-growth stocks for young investors.

Via InvestorPlace

3 Biotech Stocks to Buy With Explosive Upside Potential ↗

June 22, 2023

These three biotech stocks with high upside potential also display some significant risk, but less so than many of their small-cap peers.

Via InvestorPlace

Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript ↗

May 02, 2023

HRMY earnings call for the period ending March 31, 2023.

Via The Motley Fool

Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates

May 02, 2023

From Harmony Biosciences

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm

April 23, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

7 Stocks to Buy to Bag Big-Time Returns in Q2 ↗

April 16, 2023

If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023 ↗

April 20, 2023

Via Benzinga

NASDAQ:HRMY Shareholder Alert: Investigation over Possible Securities Laws Violations by Harmony Biosciences Holdings, Inc. ↗

April 14, 2023

San Diego, CA -- (SBWIRE) -- 04/14/2023 -- An investigation was announced for investors of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) shares over potential securities laws violations by Harmony...

Via SBWire

Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm

April 12, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months ↗

April 12, 2023

Recent, positive clinical data released by Novavax (NVAX) indicates that NVAX stock could surge almost 12 times in the next year.

Via InvestorPlace

7 Biotech Stocks to Buy for 100% Returns ↗

April 09, 2023

If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

Via InvestorPlace

Bragar Eagel & Squire, P.C. Is Investigating Nutanix and Harmony and Encourages Investors to Contact the Firm

April 02, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

All News about Harmony Biosciences Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today